Search - tctmd.com

Displaying 221 - 240 of 259

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Conference News SCAI 2017

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

L.A. McKeown

May 18, 2017

News Industry News

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

May 12, 2017

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

News Daily News

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Todd Neale

May 05, 2017

News Conference News EAS 2017

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

Yael L. Maxwell

May 01, 2017

News Conference News EAS 2017

EAS Consensus Document Strives to Banish Skepticism Over LDL Cholesterol’s Causal Role in Atherosclerosis

Yael L. Maxwell

April 24, 2017

News Conference News ACC 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

Shelley Wood

March 23, 2017

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

Todd Neale

March 18, 2017

News Conference News ACC 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

L.A. McKeown

March 18, 2017

News Conference News ACC 2017

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

Yael L. Maxwell

March 17, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

Todd Neale

March 10, 2017

News Daily News

Four-in-One Blood Pressure Pill Shows Promise as Initial Therapy

Shelley Wood

February 24, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2017

Caitlin E. Cox

February 01, 2017

News Daily News

Women Without Diabetes Fare as Poorly as Diabetic Men Post-PCI

L.A. McKeown

January 30, 2017

News Daily News

Even With Early Invasive Strategy in NSTE ACS, Women Face Poorer Outcomes Than Men

Caitlin E. Cox

January 24, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Industry News

Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds

November 21, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for May 2017

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

EAS Consensus Document Strives to Banish Skepticism Over LDL Cholesterol’s Causal Role in Atherosclerosis

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

Four-in-One Blood Pressure Pill Shows Promise as Initial Therapy

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

TCTMD’s Top 10 Most Popular Stories for January 2017

Women Without Diabetes Fare as Poorly as Diabetic Men Post-PCI

Even With Early Invasive Strategy in NSTE ACS, Women Face Poorer Outcomes Than Men

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content